On June 22, 2026, the U.S. Department of Health and Human Services (HHS) announced the launch of Operation TrialBlazer, a coordinated effort ...
Buy thesis: undervalued despite 700% surge, $193M cash runway to 2029, epilepsy & schizophrenia pipeline catalysts. See more ...
Early skin-to-skin contact after vaginal birth reduced newborn stress during routine vitamin K injection and improved ...
Detailed price information for Tvardi Therapeutics Inc (TVRD-Q) from The Globe and Mail including charting and trades.
Data presented at EULAR 2026 confirm that tight disease control can lead to safe pregnancies but also expose a critical need ...
YouTube on MSNOpinion
A concise masterclass on cholesterol-lowering medications
A concise, high-yield guide to cholesterol-lowering therapies—statins, Zetia, PCSK9 inhibitors, bempedoic acid, berberine, ...
Insilico Medicine has initiated a Phase III clinical trial of Rentosertib, a potentially first-in-class oral TNIK inhibitor for idiopathic pulmonary fibrosis discovered using the company’s Pharma.AI ...
Zacks Small Cap Research on MSN
OTC Markets Life Sciences Investor Forum: Dr. Phillip Chan, CEO, and Pete Mariani, CFO, of CytoSorbents with Zacks SCR’s Tom Kerr, CFA
NASDAQ: CTSO Greg Young: Hello and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we're very pleased you have joined us. The next ...
Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the ...
Though researchers have been studying the animal deworming drug ivermectin for decades, there is no evidence that it’s a safe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results